Joint Topic: Anticoagulation Therapy Anticoagulation Alphabet Soup: VKAs, LMWHs, and DOACs (214-1)

11:30 am – 12:30 pm Friday, October 29

Treatment of thrombosis in pediatric patients presents many challenges. Thrombosis in pediatric patients has a wide range of etiologies, and researchers lack consensus about duration of therapy based on the thrombosis location and the presence of risk factors. Most patients under 18 years of age are treated with either parenteral low-molecular-weight heparins (LMWH) or vitamin K antagonists (VKAs).

However, direct oral anticoagulants (DOACs) are also emerging as a potentially viable option in the treatment of children. Nurses play a key role in conducting patient and family education on symptoms of thrombosis, medication administration, bleeding precautions, and preventative measures as well as in encouraging patient adherence. Several cases of thrombosis patients will be reviewed.

Ashleigh Brown, BSN RN CPN CPHON®
CNE Hours:
RX Hours: